We're available 24/7. Call us anytime. (888) 552-6760
(888) 552-6760 SCHEDULE AN APPOINTMENT

Joanne M. Jeter,

Medical Oncologist

Biography photo
Location
Duarte Comprehensive Cancer Center
1500 East Duarte Road
Duarte, CA 91010
Education
Medical school:
Board Certifications
  • 2012, American Board of Internal Medicine (Internal Medicine)
  • 2005, American Board of Internal Medicine (Medical Oncology)
Degrees

  • 2005, Master of Science, Clinical Trials Design and Statistical Analysis, University of Michigan, Ann Arbor, Michigan

  • 1999, Doctor of Medicine, University of Texas Health Sciences Center at Houston, Texas

Fellowship
  • 2005, University of Michigan Medical School Ann Arbor, Michigan
Residency
  • 2002, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama
Internship
  • 2000, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama
Professional Experience
  • 2023-present, Clinical Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, California
  • 2023, Professor, Division of Medical Oncology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah
  • 2015-2020, Attending Physician, The Ohio State University, Wexner Medical Center, Columbus, Ohio
  • 2015-2020, Associate Professor of Medicine, Sections, Human Genetics and Medical Oncology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio
  • 2014-2015, Associate Professor of Medicine, Section, Hematology/Oncology, Department of Medicine, University of Arizona Cancer Center, Tucson, Arizona
Academic Appointments
  • Clinical Professor, Department of Medical Oncology & Therapeutics Research
About Me

Recognizing that each patient has a unique story, Joanne Jeter, M.D., strives to have a positive impact on that story as an expert in clinical cancer genomics. She relishes the chance to help patients manage their genetic risk, educating them about their options so they can make more informed decisions and influencing how their family members approach their own cancer risk.

Named a fellow of the American Society of Clinical Oncology (ASCO) shortly before joining City of Hope® in 2023, Dr. Jeter is a seasoned clinical researcher with a many peer-reviewed scientific publications to her name. Her investigations have been funded by the National Cancer Institute, SWOG (formerly the Southwest Oncology Group) and ASCO. Dr. Jeter has given invited lectures internationally on oncology, end-of-life care and cancer genetics. Before joining City of Hope, she held faculty appointments at the University of Utah, Ohio State University and the University of Arizona.

She was drawn to City of Hope for its reputation for groundbreaking cancer care. "As I saw more and more of my respected colleagues gravitate to the program at City of Hope and heard about the leading-edge work they strive to do,” she says, “I knew I wanted to be a part of it.”

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.